On September 28, 2022, the company announced that it has extended its plan duration till October 2, 2042.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,670 KRW | -1.57% | -5.58% | -9.35% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-9.35% | 120M | |
+21.28% | 44.4B | |
+24.47% | 23.03B | |
+19.22% | 15.14B | |
+12.87% | 13.12B | |
+44.67% | 11.85B | |
-9.92% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.52B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.